People: BioMed Realty Trust Inc (BMR.N)
BMR.N on New York Stock Exchange
20.39USD
2:59pm EDT
20.39USD
2:59pm EDT
Price Change (% chg)
$-0.27 (-1.31%)
$-0.27 (-1.31%)
Prev Close
$20.66
$20.66
Open
$20.70
$20.70
Day's High
$20.75
$20.75
Day's Low
$20.39
$20.39
Volume
161,211
161,211
Avg. Vol
513,293
513,293
52-wk High
$23.13
$23.13
52-wk Low
$18.20
$18.20
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Alan Gold |
51 | 2008 | Chairman of the Board, Chief Executive Officer |
R. Kent Griffin |
42 | 2010 | President, Chief Operating Officer |
Greg Lubushkin |
59 | 2010 | Chief Financial Officer |
Gary Kreitzer |
57 | 2012 | Executive Vice President, Director |
Matthew McDevitt |
46 | 2010 | Executive Vice President - Real Estate |
Karen Sztraicher |
2012 | Executive Vice President - Asset Management | |
Jonathan Klassen |
2012 | Senior Vice President, General Counsel | |
Daniel Bradbury |
52 | 2013 | Director |
Barbara Cambon |
59 | 2004 | Independent Director |
Edward Dennis |
70 | 2004 | Independent Director |
Richard Gilchrist |
67 | 2007 | Independent Director |
Theodore Roth |
60 | 2004 | Independent Director |
M. Faye Wilson |
74 | 2005 | Independent Director |
Biographies
| Name | Description |
|---|---|
Alan Gold |
Mr. Alan D. Gold is Chairman of the Board and Chief Executive Officer of BioMed Realty Trust, Inc. since 2004. He served as the President from 2004 until December 2008. Mr. Gold served as Chairman, President and Chief Executive Officer of the Company's privately-held predecessor, Bernardo Property Advisors, Inc., from August 1998 until August 2004. Mr. Gold was a co-founder and served as President and a director of Alexandria Real Estate Equities, Inc., a publicly traded real estate investment trust, or REIT, specializing in acquiring and managing laboratory properties for lease to the life science industry, from its predecessor’s inception in 1994 until he resigned as President in August 1998 and as a director at the end of 1998. Mr. Gold served as managing partner of Gold Stone Real Estate Finance and Investments, a partnership engaged in the real estate and mortgage business, from 1989 to 1994. He also served as Assistant Vice President of Commercial Real Estate for Northland Financial Company, a full service commercial property mortgage banker, from 1989 to 1990 and as Real Estate Investment Officer — Commercial Real Estate for John Burnham Company, a regional full service real estate company, from 1985 to 1989. Mr. Gold received his Bachelor of Science Degree in Business Administration and his Master of Business Administration from San Diego State University. He is Current director and member of the audit committee of American Assets Trust, Inc., a publicly traded REIT. |
R. Kent Griffin |
Mr. R. Kent Griffin, Jr. is President, Chief Operating Officer of BioMed Realty Trust, Inc. He has served as President and Chief Operating Officer since December 2008, also having served as Chief Financial Officer from March 2006 to May 2010. Mr. Griffin previously was part of the real estate investment banking group at Raymond James & Associates, Inc. where he was a Senior Vice President responsible for advising real estate clients on public and private equity and debt issuance, mergers and acquisitions, and other services. Prior to joining Raymond James in 2003, Mr. Griffin worked in the global real estate investment banking group of JP Morgan in both New York and San Francisco. Prior to that, Mr. Griffin was part of the real estate service group for Arthur Andersen LLP, where he was responsible for a range of audit and advisory services as a certified public accountant. Mr. Griffin received a Master of Business Administration from the University of North Carolina and a Bachelor of Science Degree in Business and Accountancy from Wake Forest University. Mr. Griffin is a member of the National Association of Real Estate Investment Trusts. |
Greg Lubushkin |
Mr. Greg N. Lubushkin has been appointed as Chief Financial Officer of BIoMed Realty Trust Inc., since May 2010. Having served as Vice President, Chief Accounting Officer from April 2007 to May 2010. From November 2004 to March 2007, Mr. Lubushkin served as Chief Accounting Officer of ECC Capital Corporation, a publicly traded mortgage REIT that invests in residential mortgage loans. From 1988 to 2004, Mr. Lubushkin was an audit partner, and from 1977 to 1988 a staff member, of PricewaterhouseCoopers LLP, a public accounting firm. Mr. Lubushkin received a Bachelor of Science Degree in Business Administration (Accounting and Finance emphasis) from the University of California at Berkeley. Mr. Lubushkin is a member of the American Institute of Certified Public Accountants and the California Society of Certified Public Accountants. |
Gary Kreitzer |
Mr. Gary A. Kreitzer has served as Executive Vice President, Director of BioMed Realty Trust, Inc. He resigned as General Counsel of the Company. Mr. Kreitzer also served as Executive Vice President, General Counsel and director of the privately-held predecessor, Bernardo Property Advisors, Inc., from December 1998 until August 2004, Co-founder, Senior Vice President and In-House Counsel of Alexandria Real Estate Equities, Inc. from its predecessor’s inception in 1994 until December 1998, In-House Counsel and Vice President for Seawest Energy Corporation, an alternative energy facilities development company, from 1990 to 1994, In-House Counsel, Secretary and Vice President for the Christiana Companies, Inc., a publicly traded investment and real estate development company, from 1982 to 1989. He holds Bachelor of Arts Degree in Economics from the University of California, San Diego, Juris Doctor Degree, with honors, from the University of San Francisco, Member of the California State Bar and the American Bar Association. |
Matthew McDevitt |
Mr. Matthew G. McDevitt serves as Executive Vice President - Real Estate of BioMed Realty Trust Inc since February 2010. Having served as Executive Vice President, Acquisitions and Leasing from February 2008 to February 2010 and Regional Executive Vice President from February 2006 to February 2008, and having joined in 2004 as Vice President, Acquisitions. Mr. McDevitt previously served as President of McDevitt Real Estate Services, Inc. (“MRES”), which Mr. McDevitt formed in October 1997 as a full service real estate provider focusing on the life science industry. Before founding MRES, Mr. McDevitt spent ten years as a commercial real estate broker in the Washington, D.C. metropolitan area. Mr. McDevitt received his Bachelor of Arts Degree in Business from Gettysburg College. |
Karen Sztraicher |
Ms. Karen A. Sztraicher has been appointed as Executive Vice President - Asset Management of BioMed Realty Trust, Inc., effective 21 August 2012. Ms. Sztraicher's distinguished career includes experience in asset management and real estate accounting and finance. During her tenure at BioMed Realty, she has served in a range of capacities with a wide scope of responsibilities, most recently overseeing asset management and real estate operations as Senior Vice President, Asset Management. Prior to joining Bernardo Property Advisors, the predecessor to BioMed Realty, Ms. Sztraicher held a variety of senior positions in real estate accounting, finance and asset management at GMS Realty, LLC, CB Richard Ellis and Donahue Schriber. She became a certified public accountant in 1988 and received her Bachelors of Science Degree from Cal State Polytechnic University, Pomona. |
Jonathan Klassen |
Mr. Jonathan P. Klassen has been appointed as Senior Vice President, General Counsel of BioMed Realty Trust, Inc., effective 21 August 2012. Mr. Klassen joined the company just after its initial public offering in 2004 and has served as a Vice President since 2006, as the company's Secretary since 2008 and as the company's Assistant General Counsel since 2010. Prior to joining BioMed Realty in 2004, Mr. Klassen was with Latham & Watkins LLP, where he focused on corporate finance transactions, mergers and acquisitions and general company representation. Mr. Klassen received his Juris Doctor Degree from the University of Pennsylvania and is a member of the California State Bar and San Diego County Bar Association. |
Daniel Bradbury |
Mr. Daniel M. Bradbury has been appointed as the Director of BioMed Realty Trust, Inc. Mr. Bradbury is the Managing Member of BioBrit, LLC, a life sciences consulting and investment firm. He served as Chief Executive Officer of Amylin Pharmaceuticals, Inc., from March 2007 until its acquisition by Bristol-Myers Squibb Company in August 2012. Mr. Bradbury served as Amylin’s President from June 2006 until March 2007, as Chief Operating Officer from June 2003 until June 2006, as Executive Vice President from June 2000 until June 2003, and other positions in corporate development and marketing from 1994 until 2000. In addition, Mr. Bradbury was a member of the board of directors of Amylin from June 2006 until August 2012. Prior to joining Amylin, Mr. Bradbury spent ten years at SmithKline Beecham Pharmaceuticals, holding a number of sales and marketing positions. Mr. Bradbury is currently a member of the boards of directors of Illumina, Inc., Geron Corporation, Corcept Therapeutics Inc. and Castle Biosciences, Inc. and the board of trustees for the Keck Graduate Institute of the Claremont Colleges. Mr. Bradbury also serves on the Advisory Council of the University of California San Diego’s Rady School of Management, the RAND Health Board of Advisors, and the University of Miami’s Innovation Corporate Advisory Council. He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom. |
Barbara Cambon |
Ms. Barbara R. Cambon has been an Independent Director of BioMed Realty Trust Inc., since 2004. Ms. Cambon has served as Real estate advisor and independent consultant since October 2002, Principal of Colony Capital, LLC, a private real estate investment firm, from November 1999 to October 2002, and Chief Operating Officer from April 2000 until October 2002, President and founder of Institutional Property Consultants, Inc., a real estate consulting company, from 1985 to October 1999. Current director, member of the audit committee and chair of the conflicts committee of each of KBS Real Estate Investment Trust, Inc., KBS Real Estate Investment Trust II, Inc. and KBS Real Estate Investment Trust III, Inc. She holds Bachelor of Science Degree in Education from the University of Delaware, Master of Business Administration with an emphasis in real estate and finance from Southern Methodist University. |
Edward Dennis |
Dr. Edward A. Dennis, Ph.D. has been an Independent Director of BioMed Realty Trust Inc., since 2004. He has been Distinguished Professor and former Chair of the Department of Chemistry and Biochemistry and Distinguished Professor of the Department of Pharmacology in the School of Medicine at the University of California, San Diego, having served as a faculty member since 1970, Visiting Professor at Harvard Medical School, Brandeis University, Université Pierre et Marie Curie and Collège de France, and Adjunct Professor at The Scripps Research Institute, Authored over 340 research articles and books and holds numerous life sciences patents, Co-founder of several privately-held life science companies, Governing boards of several professional organizations serving the life science industry, consulting and science advisory board experience in the life science industry. He has been Director of Biocept, Inc. since 2008, Member of the Board of Trustees of The ResMed Foundation from 2002 to 2010 and January 2012 to present, having served as Treasurer since January 2012. Member of the University Council of Yale University since 2004, Member of the Board of Governors of the Yale University Alumni Association from 1997 to 2008, having served as Chair from 2004 to 2006, Director of The Keystone Symposia on Molecular and Cellular Biology from 1996 to 2008, having served as Chair and President from 1996 to 2004, Director of Alexis Corporation from 1995 to 2001. He holds Bachelor of Arts Degree from Yale University, Master of Arts and Doctorate of Philosophy in Chemistry from Harvard University, Research Fellow at Harvard Medical School, Doctorate in Medicine (honorary) from Goethe University. |
Richard Gilchrist |
Mr. Richard I. Gilchrist has been an Independent Director of BioMed Realty Trust, Inc., since December 2007. Mr. Gilchrist has served as Senior Advisor of The Irvine Company, a privately held real estate investment company, with responsibility for acquisitions and investments, since July 2011, President of the Investment Properties Group of The Irvine Company from 2006 to 2011, Executive officer of various affiliates of The Irvine Company from 2006 to 2011, President and Co-Chief Executive Officer and on the board of directors of MPG Office Trust Inc. (formerly Maguire Properties, Inc.), a publicly held REIT, from 2002 to 2006, Chief Executive Officer and President of Commonwealth Atlantic Properties, a privately held REIT, from 1997 to 2001. Director of Ventas, Inc., a publicly traded REIT, since July 2011 and member of the compensation committee since December 2011, Director of various affiliates of The Irvine Company from 2006 to 2011, Director, chairman of the investment and risk assessment committee and member of the compensation committee of Nationwide Health Properties, Inc., a publicly traded REIT, from 2008 to 2011, Current member of the Whittier College Board of Trustees, and chairman from 2003 to 2011, Member of the Advisory Board of the University of California, Los Angeles Law School , Director of Commonwealth Atlantic Properties from 1997 to 2001. He holds Bachelor of Arts Degree from Whittier College, Juris Doctor Degree from University of California, Los Angeles Law School. |
Theodore Roth |
Mr. Theodore D. Roth has been an Independent Director of BioMed Realty Trust Inc., since 2004. Mr. Roth has served as President of Roth Capital Partners, LLC, an investment banking firm, since July 2010, and Managing Director from February 2003 to June 2010, President, Chief Operating Officer and other senior management positions at Alliance Pharmaceutical Corp. for over 15 years prior to joining Roth Capital Partners, LLC. Director of Targeson, Inc., a privately-held biotechnology company, since 2009, Director of Alliance Pharmaceutical from 1998 to 2009. Director of Orange 21 Inc. from 2005 to 2009, Member of the Iowa Wesleyan College Board of Trustees since 2010. He holds Juris Doctor Degree from Washburn University, Master of Laws in Corporate and Commercial Law from the University of Missouri in Kansas City. |
M. Faye Wilson |
Ms. M. Faye Wilson has been an Independent Director of BioMed Realty Trust Inc., since January 2005. Ms. Wilson has served as Chair of Wilson Boyles and Company LLC, a business management and strategic planning consulting firm, and principal since 2003, Senior officer of The Home Depot, Inc. from 1998 through 2002, Senior management roles at Bank of America Corporation from 1992 to 1998, including senior assignments in corporate finance in the United States and Europe, Chairman of Security Pacific Financial Services and Executive Vice President and Chief Credit Officer for Bank of America’s National Consumer Banking Group. She has been Member of the Salk Institute Board of Trustees since 2010, Director of Farmers Insurance Group of Companies from 1993 through 2001, Director of Home Depot from 1992 through 2001. She holds Undergraduate Degree from Duke University, Master’s Degree in International Relations from the University of Southern California, Master’s Degree in Business Administration from the University of Southern California, Became a certified public accountant in 1961. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Alan Gold |
5,267,880 |
R. Kent Griffin |
3,124,180 |
Greg Lubushkin |
1,506,450 |
Gary Kreitzer |
197,060 |
Matthew McDevitt |
2,371,690 |
Karen Sztraicher |
-- |
Jonathan Klassen |
-- |
Daniel Bradbury |
-- |
Barbara Cambon |
-- |
Edward Dennis |
-- |
Richard Gilchrist |
-- |
Theodore Roth |
-- |
M. Faye Wilson |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Alan Gold |
0 | 0 |
R. Kent Griffin |
0 | 0 |
Greg Lubushkin |
0 | 0 |
Gary Kreitzer |
0 | 0 |
Matthew McDevitt |
0 | 0 |
Karen Sztraicher |
0 | 0 |
Jonathan Klassen |
0 | 0 |
Daniel Bradbury |
0 | 0 |
Barbara Cambon |
0 | 0 |
Edward Dennis |
0 | 0 |
Richard Gilchrist |
0 | 0 |
Theodore Roth |
0 | 0 |
M. Faye Wilson |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
CAMBON BARBARA R |
3,793 | $0.00 |
GILCHRIST RICHARD I |
3,793 | $0.00 |
ROTH THEODORE D |
3,793 | $0.00 |
GOLD ALAN D |
7,000 | $0.00 |
BRADBURY DANIEL M |
3,793 | $0.00 |
WILSON MARGARET FAYE |
3,793 | $0.00 |
GOLD ALAN D |
7,000 | $0.00 |
DENNIS EDWARD A |
3,793 | $0.00 |
WILLEY STEPHEN A |
3,495 | $20.97 |
WILLEY STEPHEN A |
4,204 | $0.00 |
LUBUSHKIN GREG |
24,988 | $0.00 |
KREITZER GARY A |
4,139 | $0.00 |
MCDEVITT MATTHEW G |
26,516 | $0.00 |
GRIFFIN R KENT JR |
51,380 | $0.00 |
GOLD ALAN D |
100,260 | $0.00 |
MCDEVITT MATTHEW G |
6,346 | $0.00 |
LUBUSHKIN GREG |
2,640 | $0.00 |
MCDEVITT MATTHEW G |
20,227 | $19.33 |
GOLD ALAN D |
73,474 | $19.33 |
WILLEY STEPHEN A |
1,072 | $19.33 |
BRADBURY DANIEL M |
4,139 | $0.00 |
LUBUSHKIN GREG |
10,388 | $19.33 |
GRIFFIN R KENT JR |
38,478 | $19.33 |
ROTH THEODORE D |
2,000 | $0.00 |
GOLD ALAN D |
50,000 | $19.20 |

